## Abstract Catalase was chemically modified with a monoactivated dextran derivative having a carboxylate group at its reducing end residue. The modified enzyme retained 77% of its initial specific activity and was 3‐fold more resistant to tryptic degradation. The plasma half‐life time was increase
Improved Pharmacokinetics Properties for Catalase by Site-Specific Glycosidation with Aminated Dextran
✍ Scribed by Yunel Pérez; Aymara Valdivia; Hector L. Ramírez; Reynaldo Villalonga
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 162 KB
- Volume
- 26
- Category
- Article
- ISSN
- 1022-1336
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Summary: Catalase was chemically modified with an end‐group aminated dextran derivative via a carbodiimide catalyzed reaction. The enzymatic activity of catalase was increased after glycosidation with 4 mol of polymer. This modification improved the pharmacokinetic behavior of catalase, increasing by 7.8‐ and 20‐fold the plasma half‐life times for the α and β phases, and reducing by 176‐fold the total clearance after intravenous administration in rats.
Schematic of the catalase dextran conjugate synthesized here.
imageSchematic of the catalase dextran conjugate synthesized here.
📜 SIMILAR VOLUMES
## Abstract **Summary:** __O__‐Carboxymethylchitin (molecular weight = 1.07 × 10^5^, degree of carboxymethylation = 80%, degree of __N__‐acetylation = 91%) was chemically attached to superoxide dismutase by the formation of amide linkages through a carbodiimide catalyzed reaction. The glycosidated